AstraZeneca is investing $ 360 million in a new plant in Ireland, European media reported. The company is expected to work on the development and marketing of new drugs. A statement from the pharmaceutical group said the production facility was next-generation and would be located in Dublin.
The global supply network will be maintained from the Irish capital. There was immediate speculation that the production center would develop an improved vaccine against Covid-19, as well as drugs against coronavirus, but there is no official confirmation of this at the moment.
AstraZeneca has sold $ 1.2 billion worth of COVID-19 vaccines
The British-Swedish company has increased its revenue by 23% to $ 15.5 billion
–
The new plant is expected to create about 100 highly skilled direct jobs, including for scientists and engineers. Using the latest technology, the new plant will allow early commercial deliveries.
“Our new production will have the opportunity to create a wide range of drugs, including new and very innovative, some related to the development of antibodies against viruses,” said Pam Cheng, the company’s executive vice president.
The future production of AstraZeneca includes the creation of pharmaceutical products with very complex synthesis, requiring the latest generation of technologies and which will be able to respond to rapidly changing clinical and commercial needs. This significant investment will ensure that the company’s supply network is fit for the future, emphasize AstraZeneca.
:quality(80)/cdn-kiosk-api.telegraaf.nl/fafaf48c-1bb1-11ec-b239-02c309bc01c1.jpg?resize=150%2C150&ssl=1 "Prince Andrew has accepted subpoena: ‘He will fight’ | Royals")